Top US Marijuana Stocks to Watch in December 2025
The U.S. cannabis industry continues evolving in 2025. Investors are watching major multi-state operators closely as legalization debates continue. Many traders remain cautious after repeated sector pullbacks. However, long-term growth expectations still look strong. Because of this, investors are searching for companies with real revenue, strong national footprints, and disciplined expansion plans.
Moreover, analysts expect legalization progress to continue during 2026 and 2027. Federal reform still looks uncertain today. Yet state-level expansion continues. Adult-use markets are growing quickly in several states. Medical programs are expanding across other fields. In addition, many states have legalized recreational use. Consequently, large operators with broad footprints continue benefiting from rising demand.
Going into December, three US-focused marijuana stocks deserve attention. These companies include Trulieve, Curaleaf, and Green Thumb Industries. Each company brings something different to the table. Trulieve’s leadership in Florida remains a major strength. Curaleaf holds one of the largest national footprints and international exposures. Meanwhile, Green Thumb continues generating strong revenue growth with disciplined execution. Therefore, these three stocks may appeal to long-term investors watching the sector closely.
[Read More] Cannabis REITs to Watch This December
Top U.S. Marijuana Stocks to Watch This Week
- Trulieve Cannabis Corp. (OTC: TCNNF)
- Curaleaf Holdings, Inc. (OTC: CURLF)
- Green Thumb Industries Inc. (OTC: GTBIF)
Trulieve Cannabis Corp. (TCNNF)
Trulieve remains one of the most recognized U.S. cannabis companies. The company holds its largest presence in Florida. In fact, Trulieve operates more than 190 dispensaries nationwide, with most located in Florida. The company has gradually expanded into Pennsylvania, Arizona, and several other markets. The brand focuses heavily on medical patients. It offers flower, concentrates, edibles, and vape products. Trulieve has earned a strong reputation for consistent product quality. However, it also continues watching recreational developments in many states.
Furthermore, Trulieve recently opened new stores across the Southeast. The company aims to strengthen its presence in medical markets before recreational transitions eventually take place. Although federal reform remains uncertain, Trulieve’s regional dominance in Florida gives it a competitive advantage as legalization expands. As a result, many investors see Trulieve as an important long-term growth story.
Financially, Trulieve continues showing strong revenue performance compared to many peers. The company has reported steady quarterly revenue during 2025. While growth has slowed compared to earlier years, Trulieve still holds one of the strongest financial positions among major U.S. operators. The company has focused on cost management in recent quarters. Therefore, profit margins have shown improvement compared to previous periods.
Additionally, Trulieve continues working on debt reduction and improving financial flexibility. The company remains cautious about expansion spending during slower industry conditions. Management has emphasized operational efficiency and cash flow improvements. Many analysts believe this disciplined strategy reduces long-term risk. Still, the company remains exposed to shifting regulatory conditions and price pressure. Even so, Trulieve’s market leadership in Florida remains a powerful advantage for long-term investors.
[Read More] Top U.S. Marijuana Penny Stocks to Watch in December 2025
Curaleaf Holdings, Inc. (CURLF)
Curaleaf stands among the largest cannabis operators in the United States. The company maintains a wide national footprint, with more than 140 dispensaries. Curaleaf’s largest presence includes New Jersey, Arizona, and Florida. The company continues building a diversified product portfolio. This includes flower, edibles, topicals, and wellness products. Curaleaf also sells CBD and hemp products through national retail chains.
Unlike many competitors, Curaleaf also operates in international markets. The company maintains operations in Europe and sees long-term potential outside the U.S. While international markets remain early, Curaleaf expects future revenue growth across medical regions overseas. Meanwhile, U.S. expansion remains steady as more states advance adult-use legalization. Consequently, Curaleaf continues positioning itself for long-term industry leadership.
From a financial standpoint, Curaleaf remains one of the top revenue producers in the U.S. cannabis sector. The company continues reporting strong sales during 2025. However, profitability remains a challenge similar to most industry peers. Curaleaf has emphasized expense reductions and improved operational efficiency. Management expects margin improvements over the next several quarters.
Moreover, Curaleaf continues managing debt and strengthening its balance sheet. Investors should watch cash levels closely. The company still spends capital expanding markets and product lines. Even so, revenue scale gives Curaleaf a long-term advantage. Analysts expect continued growth if legalization momentum continues. Although short-term volatility remains high, Curaleaf’s broad geographic footprint supports long-term investor confidence.
[Read More] Canadian Cannabis Market Outlook for December 2025: Key Trends for Investors
Green Thumb Industries Inc. (GTBIF)
Green Thumb Industries operates more than 90 stores across the United States. The company’s largest presence includes Illinois, Florida, and Pennsylvania. Green Thumb focuses heavily on branded consumer products. The portfolio includes well-known brands such as RYTHM and Dogwalkers. The company also develops edible and wellness products. Green Thumb has positioned itself around product innovation and brand building.
Additionally, Green Thumb continues expanding its retail presence across important growth markets. Many of these states show rising adult-use demand. The company’s strategy focuses on both retail and wholesale channels. While competition remains intense, Green Thumb has maintained disciplined expansion. Therefore, analysts often describe Green Thumb as one of the most balanced operators in the sector.
Financially, Green Thumb has delivered impressive revenue growth compared to many rivals. The company continues reporting consistent quarterly revenue increases during 2025. Furthermore, Green Thumb has shown strong gross margins relative to peers. The company’s disciplined approach helps protect profitability during industry volatility.
Green Thumb has also maintained controlled expenses and focused resources on the most profitable markets. As a result, cash flow performance continues improving. Analysts have highlighted Green Thumb’s ability to manage growth responsibly. Although risks remain similar to other operators, Green Thumb maintains one of the strongest financial profiles in the industry. Consequently, the company remains an attractive long-term cannabis investment heading into 2026.
[Read More] 3 Great Marijuana Stocks To Help Build Your Long-term Portfolio
Final Thoughts
These three U.S. cannabis leaders remain important names to watch in December 2025. Each company continues navigating challenging industry conditions. However, strong footprints and disciplined financial strategies support long-term potential. While volatility may persist, long-term growth trends continue favoring large multi-state operators.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
